Intervention strategies to prevent pathogenetic effects of glycated albumin.
about
The antioxidant properties of serum albuminUse of Raman spectroscopy for the identification of radical-mediated damages in human serum albumin.The role of ribosylated-BSA in regulating PC12 cell viability.Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injurySerum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Comparative proteomic analysis of gallbladder bile proteins related to cholesterol gallstonesAstragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells.Aqueous extract of some indigenous medicinal plants inhibits glycation at multiple stages and protects erythrocytes from oxidative damage-an in vitro study.Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathyGlycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.Glycated albumin: a potential biomarker in diabetes.Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin.Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine.Antioxidant capacity and structural changes of human serum albumin from patients in advanced stages of diabetic nephropathy and the effect of the dialysis.Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.Oxidative damage in diabetics: insights from a graduate study in La Reunion University.Inhibitors of thermally induced burn incidents – characterization by microbiological procedure, electrophoresis, SEM, DSC and IR spectroscopy.Glycated albumin. A glycemic control index to be reevaluated
P2860
Q28279790-E0546235-8204-4669-A6F7-15234F1EBAB0Q30401865-2524ED21-E402-4C6B-BB6B-2F6D9F6BE12AQ30416154-96A947AB-6605-4914-936C-80890FD1BC4CQ33556839-6403DD08-BEC2-4C33-88E1-A86E30AEF157Q34250328-969FEDAA-A2F1-43D1-9EE6-11270C3F7580Q34563185-61B84DE4-BB8B-4AAA-BC23-E3AD1B1D40B2Q34747187-FC7EA69D-C350-4B4C-8C2D-4791893351A6Q35220870-93696A8A-FD92-4E5B-861A-E4E04E14B403Q36807461-1A258457-D963-45F6-8E50-DACEAF509EE1Q37181988-0EB6E202-6755-4D47-B62E-37773C33DA22Q38340062-4D4AC122-A78D-48C7-A995-17D4857995C4Q39430493-E5FE1DF9-F880-4B04-91F6-5D2855594254Q40077740-3028300B-BC9E-4B19-8012-688C7A4DC861Q40397852-381EDFE9-FEFD-41BB-AC1F-FE8510CBF56AQ41251505-0BB6A199-B6B4-4B39-B5B0-52D8FF2F04A2Q41938287-4373E250-D7E1-4AE6-BA94-694A55FFC6D5Q50643852-A2C72F68-C16E-482F-8BB2-D014FC564ED6Q54267289-745DF757-4E86-46D8-8BFF-2B29D17DC859Q58055764-9881227F-A9D8-49E6-8235-8A62A169D8D4
P2860
Intervention strategies to prevent pathogenetic effects of glycated albumin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@ast
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@en
type
label
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@ast
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@en
prefLabel
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@ast
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@en
P1476
Intervention strategies to prevent pathogenetic effects of glycated albumin.
@en
P2093
Margo P Cohen
P356
10.1016/J.ABB.2003.08.012
P407
P577
2003-11-01T00:00:00Z